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The epidermis is a self-renewing tissue, the homeostasis of which is dependent upon the tight balance between
proliferation and differentiation based on appropriate regulation of the cell cycle. The cell cycle regulation is
dependent on the interactions among a number of cell cycle regulatory molecules, including the pituitary
tumor-transforming gene 1 (PTTG1), also known as securin, a regulator of sister chromatid separation and
transition from metaphase to anaphase. This study was conducted to clarify the less-known functions of PTTG1
in the epidermis by the use of keratinocytes cultured under two-dimensional (2D) or three-dimensional (3D)
conditions. Forced overexpression of PTTG1 caused upregulation of cyclin B1, cyclin-dependent kinase 1
(CDK1), and c-Myc, resulting in enhanced proliferation and suppression of early differentiation without
apparent alterations in terminal differentiation, and the exogenous PTTG1 was downregulated in association
with cell cycle exit. In contrast, depletion of PTTG1 caused their downregulation and constrained proliferation
with retention of differentiation capacity. These findings suggested that PTTG1 could alter the proliferation
status by modulating the expression levels of the other cell cycle regulatory proteins, and excess PTTG1
primarily affects early differentiation of keratinocytes under the stability regulation associated with cell
cycle exit.
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INTRODUCTION
Accurate regulation of cell proliferation and differentiation is
critical for the maintenance of self-renewing tissues, such as
the epidermis, a stratified epithelium consisting of keratino-
cytes. Within the epidermis, proliferation is principally
confined to the basal layer and differentiation occurs as
keratinocytes migrate through the suprabasal layers after
growth arrest, namely, cell cycle exit (Gandarillas et al.,
2000; Fuchs and Horsley, 2008). When the balance leans
toward proliferation and differentiation is suppressed, epi-
dermal proliferative disorders occur, such as squamous cell
carcinoma and psoriasis. This relationship relies on the
interactions among the numerous cell cycle regulatory
molecules, such as cyclins, cyclin-dependent kinases (CDKs),
CDK inhibitors, and transcription factors such as p53 (Muller,
1995; Di Cunto et al., 1998), which are known to alter
keratinocyte proliferation and differentiation under several
experimental settings (Di Cunto et al., 1998; Hauser et al.,
2004; Truong et al., 2006; Watt et al., 2008; Wong et al.,
2010).
Pituitary tumor-transforming gene 1 (PTTG1), initially
identified as a protooncogene (Pei and Melmed, 1997) and
later characterized as vertebrate securin (Zou et al., 1999),
is expressed abundantly in multiple cancer cell types,
and its transforming activity has been demonstrated experi-
mentally (Panguluri et al., 2008; Tong and Eigler, 2009).
PTTG1 possesses transcriptional activity in its C-terminal
region and has several validated transcriptional targets, such
as c-myc and basic fibroblast growth factor. As a cell
cycle regulatory protein, PTTG1 has a role in the regulation
of sister chromatid separation and transition from metaphase
to anaphase, functions as securin, and shows interactions
with other cell cycle regulatory molecules such as CDK1
(Ramos-Morales et al., 2000), CDK inhibitor p21WAF1/Cip1
(Chesnokova et al., 2007), and p53 (Yu et al., 2000a).
In normal tissue, PTTG1 expression is restricted and
highly expressed in the testis in a stage-specific manner
during spermatogenesis, suggesting that PTTG1 may have
a role in male germ cell differentiation (Ramos-Morales
et al., 2000). These observations indicate that PTTG1
has important functions in proliferation and differentiation.
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However, its physiological function in the epidermis remains
to be elucidated.
This study was conducted to investigate the role of
PTTG1 in keratinocyte proliferation and differentiation using
HaCaT cells, normal human keratinocytes (NHKs), and
neonatal murine keratinocytes (NMKs) cultured under two-
dimensional (2D) or three-dimensional (3D) conditions.
PTTG1 overexpression enhanced proliferation and upregu-
lated the levels of cyclin B1, CDK1, and c-Myc expression at
both protein and mRNA levels. Excess PTTG1 protein was
downregulated in association with cell cycle exit and
suppressed early differentiation without significant alterations
in terminal differentiation. These findings suggested that
PTTG1 might maintain the proliferative phenotype in
keratinocytes by delaying cell cycle exit.
RESULTS
PTTG1 expression in normal keratinocytes is under cell
cycle–dependent regulation
The in vivo expression of PTTG1 in epidermal keratinocytes
was confirmed by immunostaining of normal human skin
with an antibody against PTTG1 protein. PTTG1 was shown
to be expressed in a small fraction of the basal and peribasal
keratinocytes, and was localized in the nucleus and
cytoplasm (Figure 1a). Some PTTG1-positive keratinocytes
were located not in the basal layer but in the peribasal layer,
indicating that some peribasal keratinocytes still possessed
proliferative capacity and had not completed cell cycle exit,
as reported previously (Pinkus and Hunter, 1966; Penneys
et al., 1970; Regnier et al., 1986; Dover and Watt, 1987;
Bata-Csorgo et al., 1993; Zanet et al., 2010). Next, NMKs
were cultured in low- or high-calcium–containing medium.
NMKs cultured under high-calcium conditions undergo a
phenomenon known as calcium switch, which involves cell
cycle exit followed by terminal differentiation (Rothnagel
et al., 1993). The results of immunoblotting and quantitative
real-time PCR indicated significantly elevated PTTG1 expres-
sion in undifferentiated keratinocytes cultured under low-
calcium conditions (0.05mM calcium) at both the mRNA
and protein levels in comparison with those cultured under
high-calcium conditions (0.12mM calcium; Figure 1b and c).
Therefore, these findings indicated that PTTG1 is expressed at
high levels during the cell cycle, and is downregulated after
cell cycle exit.
PTTG1 alters the thicknesses of the epithelia formed by human
keratinocytes cultured under 3D conditions
HaCaT cells and NHKs were cultured under 3D conditions as
described in Materials and Methods to allow experimental
investigation of the effects of PTTG1 expression in epidermal
keratinocytes. In this experimental model, the thicknesses of
epithelium-like structures formed by stratified keratinocytes
can demonstrate the proliferation capacity. They were
transduced with a retroviral vector encoding rat PTTG1 and
nerve growth factor receptor (NGFR) to establish cells with
constitutive PTTG1 expression. The vector containing only
the NGFR sequence was used as a control. Exogenous PTTG1
expression was monitored at the protein level (Figure 6a).
HaCaT cells and NHKs were depleted of endogenous PTTG1
using a lentiviral vector encoding a short-hairpin RNA
(shRNA) against PTTG1, and a vector encoding scrambled
shRNA sequence was used as a negative control. Sufficient
knockdown was confirmed at the protein level (Figure 6a).
Constitutive PTTG1 expression resulted in the formation
of thicker epidermoid epithelia than the control, whereas
PTTG1 depletion resulted in the formation of thinner
epithelia than the negative control (Figure 2). These results
suggested that PTTG1 altered the thicknesses of the epider-
moid epithelia formed by human keratinocytes because of its
crucial influence on keratinocyte proliferation.
Overexpression of PTTG1 suppressed early differentiation of
human keratinocytes cultured under 3D conditions
Keratinocytes cultured under 3D conditions can mimic their
differentiation pattern under physiological conditions (Bell et al.,
1981). To analyze the effects of PTTG1 on the differentiation,
immunostaining of 3D cultured HaCaT cells (Figure 3a) and
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Figure 1. Pituitary tumor-transforming gene 1 (PTTG1) expression in normal
keratinocytes is under cell cycle–dependent regulation. (a) Immunostaining
of normal human skin with an antibody to PTTG1 protein. PTTG1 was
expressed in basal and peribasal keratinocytes, and localized in the cytoplasm
and nucleus. Bar¼100 mm. (b) Total RNAs extracted from neonatal murine
keratinocytes (NMKs) cultured in low- or high-calcium (Ca)–containing
medium were subjected to quantitative real-time PCR. Relative expression
of PTTG1 (left) and keratin 10 (K10; right) mRNA in NMKs under low- and
high-calcium conditions. PTTG1 mRNA expression level was 6.6-fold
higher under low-calcium conditions than under high-calcium conditions.
The results indicated cell cycle–dependent transcriptional regulation of
PTTG1. The expression levels were normalized relative to glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) mRNA expression. All values
represent means±SEM from three independent experiments. **Po0.01.
(c) Immunoblotting of whole-cell extracts from NMKs cultured under
low- or high-calcium conditions. PTTG1 protein expression became almost
undetectable as NMKs underwent differentiation, also indicating cell
cycle–dependent regulation.
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NHKs (Figure 3b) was performed using antibodies against
early differentiation markers of keratinocytes, K1 and K10,
along with K14 and PTTG1. In addition, NHKs were stained
with an antibody against the terminal differentiation marker
loricrin. Constitutive PTTG1 overexpression in HaCaT cells
caused decreases in the thicknesses of K1- and K10-positive
layers and increases in the thicknesses of undifferentiated
layers (Figure 3a), whereas NHKs showed an increase in the
thicknesses of undifferentiated layers, although substantial
changes in the stained layers correlated with the total
thickness change (Figure 3b). There was no apparent change
in staining pattern for loricrin (Figure 3b). On the other hand,
PTTG1 depletion had no significant effect on the staining
patterns of any of the differentiation markers despite the
changes in the total layer thickness in both HaCaT cells and
NHKs (Figure 3). These results suggested that excess PTTG1
suppresses early differentiation specifically, but the absence
of PTTG1 had no significant effect on the differentiation of
human keratinocytes.
Overexpression of PTTG1 suppressed early keratinocyte
differentiation under 2D conditions
The results of the study using HaCaT cells and NHKs
suggested that PTTG1 might suppress early keratinocyte
differentiation. To demonstrate its role in keratinocyte
differentiation under another experimental setting, an ex-
pression plasmid encoding the rat PTTG1 was transfected into
NMKs. The cells were induced to undergo differentiation by
calcium switch, allowing us to observe their two independent
biological conditions separately: during the cell cycle or after
cell cycle exit. Differentiating keratinocytes cultured under
high-calcium conditions showed marked decreases in K1 and
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Figure 2. Pituitary tumor-transforming gene 1 (PTTG1) altered the thicknesses of epithelia formed by human keratinocytes cultured under three-dimensional
(3D) conditions. (a) HaCaT cells were transduced with a retroviral vector encoding rat PTTG1 and nerve growth factor receptor (NGFR), and endogenous
PTTG1 was depleted from HaCaT cells using a lentiviral vector encoding short-hairpin RNA (shRNA) against PTTG1 (sh–PTTG1). PTTG1 expression and
sufficient knockdown were monitored by immunoblotting (see Figure 6a). Constitutive PTTG1 expression resulted in the formation of thicker epidermoid
epithelia than the control, whereas the absence of endogenous PTTG1 in HaCaT cells resulted in the formation of thinner epithelia: epidermoid epithelia formed
10 days after exposure to the air–liquid interface (hematoxylin–eosin (H&E) staining). Bar¼ 20 mm. (b) Temporal thickness measurement of the epithelia. (c)
Normal human keratinocytes (NHKs) were transduced with the PTTG- or shRNA-encoding retroviral vectors and cultured under 3D conditions, as were HaCaT
cells. Successful PTTG1 overexpression or endogenous PTTG1 knockdown was monitored by immunoblotting (see Figure 6b). PTTG1 expression resulted in the
formation of thicker epidermoid epithelia than the control, whereas the absence of endogenous PTTG1 NHKs resulted in the formation of thinner epithelia:
epidermoid epithelia formed 4 days after exposure to the air–liquid interface (H&E staining). Bar¼ 20 mm. (d) Thickness measurement of the epithelia. All values
represent means±SEM from three independent experiments. **Po0.01 versus control.
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K10 expression at both the mRNA and protein levels
(Figure 4). These observations suggested that PTTG1 also
suppressed early differentiation of normal keratinocytes
under 2D conditions.
PTTG1 altered keratinocyte proliferation patterns under both
2D and 3D conditions
Proliferation and differentiation processes are generally
independent of each other. To verify whether the suppressed
keratinocyte differentiation described above was due to
enhanced proliferation, we examined the effects of the
change in PTTG1 expression level on keratinocyte proli-
feration pattern. First, we examined the proliferative
capacity by counting the proliferation rate of HaCaT cells.
PTTG1 overexpression resulted in increased proliferation
rate, whereas depletion of PTTG1 resulted in a decrease
in proliferation rate (Figure 5a). Next, immunostaining using
an antibody against Ki67, a classic proliferation marker, was
performed to confirm the proliferative status under 3D
conditions. HaCaT cells and NHKs overexpressing PTTG1
showed increased positivity for Ki67 (Figure 5b and c),
whereas PTTG1-depleted keratinocytes showed decreased
positivity (Figure 5b and c). These results suggested that
PTTG1 has a critical role in maintaining proliferative capacity
in HaCaT cells and NHKs.
PTTG1-induced hyperproliferation is due to the upregulation
of cyclin B1, CDK1, and c-Myc oncoprotein
As enhanced proliferation is related to faster progression of
the cell cycle, we assayed the expression of endogenous cell
cycle regulatory proteins by immunoblotting. HaCaT cells,
NHKs, and NMKs overexpressing PTTG1 showed upregula-
tion of cyclin B1, CDK1, and c-Myc (Figure 6a and b). Cyclin
B1, which is expressed in the G2/M phase of the cell cycle,
forms a complex also known as mitosis-promoting factor with
the master mitotic kinase CDK1 and promotes cell cycle
progression. These upregulated cell cycle regulatory proteins
may contribute to the more rapid cell cycle progression,
resulting in enhancement of proliferation and delayed cell
cycle exit, suppressing early differentiation. Moreover, the
results of quantitative real-time PCR suggested that this
upregulation was at the mRNA level (Figure 6c). In contrast,
immunoblotting of PTTG1-depleted HaCaT cells and NHKs
revealed downregulation of these cell cycle regulatory
proteins (Figure 6). In addition, NHKs overexpressing PTTG1
caused significant upregulation of cyclin A, which is
expressed in the S/G2 phase of the cell cycle and, in contrast,
PTTG1 depletion caused its downregulation (Figure 6a).
However, there was no such change in the expression level of
cyclin D1, which is highly expressed in the G1 phase of the
cell cycle (Figure 6a). These observations suggested that
PTTG1 might modulate the expression levels of these
endogenous cell cycle regulatory proteins that are abundant
in the G2/M phase of the cell cycle. Notably, NMKs
overexpressing PTTG1 cultured under high-calcium condi-
tions showed markedly decreased expression of PTTG1
protein along with cyclin B1 and CDK1, despite its
constitutive expression as confirmed by the mRNA level
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Figure 3. Overexpression of pituitary tumor-transforming gene 1 (PTTG1)
suppressed early differentiation of human keratinocytes cultured under
three-dimensional (3D) conditions. Representative figure of HaCaT cells
and normal human keratinocytes (NHKs) cultured under 3D conditions
stained with antibodies against keratin 1 (K1) and K10 (keratinocyte early
differentiation markers), along with K14 and PTTG1. NHK was also stained
with an antibody against loricrin (a terminal keratinocyte differentiation
marker). (a) Constitutive PTTG1 overexpression in HaCaT cells caused
decreases in thicknesses of K1- and K10-positive layers and increases in
thicknesses of undifferentiated layers. (b) Constitutive PTTG1 overexpression
in NHKs was associated with an increase in the undifferentiated layers,
although substantial changes in the stained layers were correlated with the
total thickness. There was no apparent change in loricrin staining pattern.
Note the bottom-heavy staining pattern of PTTG1 despite its constitutive
overexpression. (a, b) PTTG1 depletion had no significant effect on
staining patterns of any of the differentiation markers despite the changes
in total layer thickness. NGFR, nerve growth factor receptor; sh–PTTG1,
lentiviral vector encoding a short-hairpin RNA against PTTG1.
(a) Bar¼20 mm. (b) Bar¼50 mm.
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(Figure 6c), indicating the stability regulation of the exogen-
ous PTTG1 protein in association with cell cycle exit along
with these upregulated proteins.
DISCUSSION
In the epidermis, PTTG1 expression is confined to the
proliferative layers, and undifferentiated NMKs specifically
showed PTTG1 mRNA and protein expressions. These results
indicated the cell cycle–dependent regulation of PTTG1
expression, as reported previously (Cohen-Fix et al., 1996;
Funabiki et al., 1996; Zou et al., 1999; Ramos-Morales et al.,
2000; Yu et al., 2000b). The frequency of PTTG1-positive
cells was B10% of basal or peribasal keratinocytes in the
epidermis (Figure 1a). Such low frequency of PTTG1-positive
cells may be due to the restricted periodic expression of
PTTG1 protein during the cell cycle. That is, PTTG1 protein is
expressed in the G2/M phase of the cell cycle with a peak in
mitosis (Ramos-Morales et al., 2000). In addition, we showed
that constitutive PTTG1 overexpression caused upregulation
of cyclin B1 and CDK1, which are known to form a complex
also referred to as mitosis-promoting factor. In contrast,
PTTG1 depletion resulted in their downregulation, affecting
cell cycle progression.
In the eukaryotic cell cycle, the tightly regulated expres-
sion and degradation of cell cycle regulatory proteins are
indispensable, and degradation of these molecules is
dependent on the ubiquitin–proteasome pathway (Ciechan-
over, 1998). In the G2/M phase of the cell cycle, securin
(PTTG1) and cyclin B1 accumulate at the metaphase stage of
mitosis followed by their rapid degradation, which promotes
exit from mitosis (Clute and Pines, 1999; Zur and Brandeis,
2001; Hagting et al., 2002; Peters, 2002; Herbert et al.,
2003). During this process, anaphase-promoting complex, a
ubiquitin ligase, mediates proteolysis by recognizing poly-
ubiquitination targets that will be subjected to degradation
via the proteasome, leading to the periodic expression of
these cell cycle regulatory proteins (King et al., 1995). A
growing body of evidence suggests that PTTG1 expedites
M-phase progression via stabilization of cyclin B with its
inhibitory effect on the anaphase-promoting complex acti-
vity, as demonstrated by experiments using murine oocytes
(Marangos and Carroll, 2008) or budding yeast (Cohen-Fix
and Koshland, 1999; Tinker-Kulberg and Morgan, 1999).
Thus, the results of this study may illustrate the universal
feature of PTTG1 protein regarding M-phase regulation
beyond the cell division patterns or biological classification.
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Figure 4. Overexpression of pituitary tumor-transforming gene 1 (PTTG1) suppressed early keratinocyte differentiation under two-dimensional (2D)
conditions. Neonatal murine keratinocytes (NMKs) were transfected with an expression plasmid encoding PTTG1 and induced to differentiate by
calcium (Ca) switch. (a) Representative results of immunoblotting of whole-cell lysate from differentiating NMKs cultured under high-calcium conditions.
NMKs constitutively overexpressing PTTG1 showed decreases in keratin 1 (K1) and K10 compared with NMKs transfected with pCMV empty vector.
The band intensities quantified by densitometry were significantly different. The expression levels were normalized relative to b-actin. (b) Total RNAs extracted
from NMKs were subjected to quantitative real-time PCR. Relative expression levels of K1, K10, and PTTG1 mRNA. NMKs constitutively expressing
PTTG1 showed decreases in K1 and K10 compared with NMKs transfected with pCMV empty vector. The expression levels were normalized relative to
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA expression. (a, b) The exogenous PTTG1 protein was downregulated under high-calcium
conditions despite its constitutive expression, as confirmed by detection of its mRNA. All data are means±SEM from three independent experiments.
**Po0.01 versus control. NS, not significant.
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We also showed significant changes in the expression
level of cyclin A, which is predominantly expressed in the
S/G2 phase of the cell cycle with no such change in cyclin
D1, a G1-phase cyclin, using NHKs. These observations indi-
cated that with regard to the effect on cell cycle progression,
PTTG1 protein may have a greater influence on G2/M phase
where it is abundantly expressed under physiological
conditions (Ramos-Morales et al., 2000). A study using
securin knockout cells, which showed elongation of the
metaphase-to-anaphase interval in M phase without signifi-
cant changes in other phases of the cell cycle (Jallepalli et al.,
2001), may support our findings. In addition, we showed that
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Figure 5. Pituitary tumor-transforming gene 1 (PTTG1) altered keratinocyte proliferation patterns under both two-dimensional (2D) and three-dimensional
(3D) conditions. (a) Proliferation rate was assayed by cell counting. HaCaT cells constitutively expressing PTTG1 showed increased proliferation rate
compared with controls, whereas PTTG1-depleted HaCaT cells showed a decreased proliferation rate. (b) HaCaT cells and (c) normal human keratinocytes
(NHKs) cultured under 3D conditions were stained with an antibody against Ki67. Constitutive expression of PTTG1 resulted in an increase in the number of
Ki67-positive cells, whereas depletion of PTTG1 resulted in a decrease. All values represent means±SEM from three independent experiments. NGFR, nerve
growth factor receptor; sh–PTTG1, lentiviral vector encoding a short-hairpin RNA against PTTG1. **Po0.01 versus control. Bar¼20 mm (a), 50 mm (b).
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exogenous PTTG1 protein was downregulated in calcium-
induced differentiating NMKs despite its constitutive over-
expression, suggesting the existence of a stability regulation
mechanism similar to the ubiquitin–proteasome pathway
known to have a role in M-phase regulation. Briefly, excess
PTTG1 protein appears to enhance proliferation via upregu-
lation of G2/M cell cycle accelerators, but once the
keratinocytes exit the cell cycle and undergo differentiation,
it may have little effect on later differentiation processes
because of its own downregulation, which may be consistent
with the staining pattern of loricrin without significant
alterations in NHKs overexpressing PTTG1 cultured under
3D conditions. This implies an important cell cycle regula-
tory machinery in keratinocyte differentiation. As demon-
strated by the experiments involving culture under 3D
conditions, the absence of PTTG1 protein appeared not to
disturb the differentiation capacity of keratinocytes. This is
consistent with the phenotype of PTTG knockout mice,
which were viable and fertile but showed hypoplasia in
multiple organs including the thymus, testis, and spleen, in
which the PTTG1 expression levels are high (Wang et al.,
2001). In keratinocytes, PTTG1 can alter the proliferation
status by modulating the expression levels of other cell cycle
regulatory proteins, especially those expressed in the G2/M
phase of the cell cycle, but may have little effect on terminal
differentiation itself.
In conclusion, the results of this study suggested that
PTTG1 alters the proliferation status by modulating the
expression levels of other cell cycle regulatory proteins, such
as cyclin B1, CDK1, and c-Myc. This aberrant cell cycle
regulation due to the overexpression of PTTG1 suggested that
it might have important roles in hyperproliferative disorders
in the epidermis, such as psoriasis or squamous cell
carcinoma. In addition, the stable regulation of excess PTTG1
protein in association with cell cycle exit implies the
existence of an important mechanism of cell cycle regulation
involved in keratinocyte differentiation.
MATERIALS AND METHODS
Plasmids
The plasmid pBKCMV-PTTG1 encoding the full-length PTTG1
(NM_022391) was a kind gift from Dr Songguang Ren (Cedars-Sinai
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Figure 6. Pituitary tumor-transforming gene 1 (PTTG1)-induced keratinocyte hyperproliferation is due to the upregulation of cyclin B1 (CycB1),
cyclin-dependent kinase 1 (CDK1), and c-Myc oncoprotein. (a, b) Representative immunoblotting of whole-cell lysates from HaCaT cells, normal human
keratinocytes (NHKs), and neonatal murine keratinocytes (NMKs). Cyclin B1, CDK1, and c-Myc were upregulated because of constitutive expression of PTTG1,
whereas all of these molecules were downregulated because of depletion of PTTG1. The band intensities quantified by densitometry showed significant
differences (graphs). Expression levels of cyclin A (S/G2-phase cyclin) and cyclin D1 (G1-phase cyclin) in NHKs were analyzed by immunoblotting.
Compared with cyclin D1, cyclin A expression level changed significantly according to PTTG1 expression level, showing similarity to PTTG1, cyclin B1,
and CDK1. The expression levels were normalized relative to b-actin. (c) Total RNAs extracted from NMKs were subjected to quantitative real-time PCR.
Relative expression levels of PTTG1, cyclin B1, CDK1, and c-Myc mRNA. NMKs constitutively expressing PTTG1 showed upregulation of these molecules.
The expression levels were normalized relative to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA expression. PTTG1 protein was downregulated
along with cyclin B1 and CDK1 despite constitutive mRNA expression. All data are means±SEM from three independent experiments. **Po0.01 versus
control. NGFR, nerve growth factor receptor; NS, not significant.
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Medical Center, Los Angeles, CA). The construct was confirmed by
enzymatic digestion and sequenced to verify the correct reading
frame before use.
Cell culture
HaCaT cells were maintained in MCDB153 growth medium
(Sigma-Aldrich, St Louis, MO) supplemented with 0.1mM calcium
chloride, 10 ngml–1 EGF (Sigma-Aldrich), 1% penicillin–strepto-
mycin solution (Sigma-Aldrich), and decalcified fetal bovine serum
(Gibco-BRL, Paisley, UK) as described previously (Kato et al., 1995).
NHKs (KJB-100; DS Pharma, Osaka, Japan) were cultured in serum-
free growth medium (KJB-200; DS Pharma) in accordance with the
manufacturer’s instructions. Keratinocytes within fourth passage
were used for the experiments. Primary mouse keratinocyte cultures
were prepared as described previously (Rothnagel et al., 1993). The
3D cell culture was performed as described previously (Taguchi
et al., 2011). Briefly, human dermal fibroblasts (Kurabo, Osaka,
Japan) were cultured in type I collagen gel (Cellmatrix type IA; Nitta
Gelatin, Osaka, Japan) in 12-well plates at a density of 3.0 105
cells per well (HaCaT) or 5.0 105 cells per well (NHK). After
solidification of the gels, HaCaT cells and NHKs were seeded onto
each well at densities of 1.3 105 and 5.0 105 per well,
respectively. After incubation for 72 hours, the double-layered
cultures were exposed to the air–liquid interface, underneath which
the inverted cell strainers contained 3D medium consisting of a 1:1
mixture of MCBD153 medium (HaCaT) or KJB-200 medium (NHK)
with DMEM (Wako, Osaka, Japan) supplemented with 10%
decalcified fetal bovine serum and 1% penicillin–streptomycin
solution (Falcon, Franklin Lakes, NJ) in six-well plates. The cultures
in triplicate wells were analyzed on the indicated dates. The
thicknesses of the epithelia formed were measured as described
previously (Taguchi et al., 2011).
DNA transfection
Keratinocytes from newborn mice were transfected using
TransIT-Keratinocyte Transfection Reagent (Mirus Bio, Madison,
WI). To examine mRNA or protein expression in undifferen-
tiated keratinocytes, cells were cultured in low-calcium–containing
medium for 48 hours after transfection and then harvested.
Expression in differentiated keratinocytes was assessed by cultivation
for 24 hours in low-calcium medium (0.05mM calcium) without
EGF, followed by 48 hours in high-calcium medium (0.12mM
calcium).
Retroviral production and transduction
Complementary DNA encoding PTTG1 was digested from the
plasmid and subcloned into the corresponding sites of the retroviral
vector GCDNsap containing NGFR and transduced into the
packaging cell line 293GPG along with the control vector encoding
NGFR, as described previously (Fujisawa et al., 2009). The virus
titers were B1.0 105 infectious units per ml on Jurkat cells.
The retroviral vectors were transduced into HaCaT cells or NHKs
cultured in six-well plates and then subcultured into several dishes
10 cm in diameter. Flow cytometry was performed to detect
successful transduction using a FACSCalibur (BD Biosciences,
Franklin Lakes, NJ) and LNGFR-APC antibody (Miltenyi Biotec,
Bergisch Gladbach, Germany). The efficacy of transduction was
80–90%.
Immunoblotting
Cells at 80% confluency in 10-cm culture dishes were solubilized
using Sample Buffer Solution (Wako). The whole-cell lysates were
subjected to SDS-PAGE on Mini-PROTEAN TGX Precast Gels
(Bio-Rad, Hercules, CA), and the proteins were transferred onto
nitrocellulose membranes (GE Healthcare, Buckinghamshire, UK).
The membranes were incubated overnight with primary antibodies
against PTTG1 (10 mgml–1; ab-3305; ABcam, Cambridge, UK),
keratin 10 (0.2 mgml–1; PRB-159P; Covance, Emeryville, CA), keratin
1 (0.2 mgml–1; PRB-165P; Covance), keratin 5 (0.2 mgml–1;
PRB-160P; Covance), cyclin A (10 mgml–1 RB-1548; Thermo
Fisher Scientific, Newark, DE), cyclin B1 (0.5 mgml–1 05-373SP;
Millipore, Billerica, MA), cyclin D1 (2 mgml–1; sc-718; Santa Cruz
Biotechnology, Santa Cruz, CA), c-Myc (2 mgml–1; sc-40; Santa Cruz
Biotechnology), b-actin (0.2 mgml–1; BioVision, Mountain View,
CA), and CDK1 (1 mgml–1; Millipore), followed by incubation for
60minutes with horseradish peroxidase–labeled secondary anti-
bodies against rabbit IgG (0.04 mgml–1; Santa Cruz Biotechnology)
and mouse IgG (0.4 mgml–1; Santa Cruz Biotechnology). Antibody
binding was visualized and enhanced with SuperSignal West Pico
Chemiluminescent Substrate (Thermo Fisher Scientific) and
Hyperfilm MP (GE Healthcare). The intensities of the bands were
quantified by densitometry, and the expression levels were normal-
ized relative to b-actin.
Immunohistochemical staining
Sections of 3D cultures were treated by autoclaving in 10mM citrate
buffer (pH 6.0) for antigen retrieval and incubated overnight with
primary antibodies against keratin 14 (0.1 mgml–1; MS-115; Thermo
Fisher Scientific), keratin 1 (0.5 mgml–1; PRB-149P; Covance), keratin
10 (100 ; MON 3025; Sanbio B.V., Uden, The Netherlands),
loricrin (0.5 mgml–1; PRB-145P; Covance), and Ki67 (0.05mgml–1;
ab833; ABcam), followed by visualization using an EnVision kit
according to the standard protocol (Dako, Glostrup, Denmark) and
counterstaining with hematoxylin.
Quantitative real-time PCR analysis
Total RNA was extracted from 10-cm culture dishes at 80–90%
confluency using ISOGEN (Nippon Gene, Tokyo, Japan), and
complementary DNA was synthesized using a Prime Script RT
reagent kit (Takara Bio, Shiga, Japan). An ABI PRISM 7000 Sequence
Detection System (Applied Biosystems, Foster City, CA) was used for
SYBR Green (Takara Bio)–based quantitative analysis. The quantity
of mRNA was normalized relative to that of glyceraldehyde-3-
phosphate dehydrogenase (GAPDH). Quantification was performed
in triplicate. The primers used were as follows:
Keratin 10: (forward: 50-CTGACAATGCCAACGTGCTG-30;
reverse: 50-GCAGGGTCACCTCATTCTCGTA-30) PTTG1 (mouse):
(forward: 50-TTTGGCATCTAAGGATGGGTTGA-30; reverse: 50-AGC
ATTGAACACTTTGCCGACTC-30) PTTG1 (rat) (forward: 50-GGCTT
GCCTAAAGCCACCAG-30; reverse: 50-GTAGGCATCATCAGGAGC
AGGAG-30) cyclin B1 (forward: 50-TGAGCCTGACCTGAACCTG-30;
reverse: 50-GTTTCCATCGGGCTTGGAGA-30) CDK1 (forward: 50-AC
TGGCTGATTTCGGCCTTG-30; reverse: 50-CAGCAACACTTCTGGA
GATCGGTA-30) c-Myc (forward: 50-CCTAGTGCTGCATGAGGAG-30;
reverse: 50-GGATGGAGATGAGCCCGAC-30) GAPDH (forward:
50-AAATGGTGAAGGTCGGTGTGAAC-30; reverse 50-CAACAATCTC
CACTTTGCACTG-30).
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Depletion of PTTG1 via shRNA
Lentiviral particles encoding shRNA targeting PTTG1 mRNA were
purchased from Santa Cruz Biotechnology (sc-37491-V). Lentiviral
particles encoding a scrambled shRNA sequence (sc-108080) were
also purchased from the same source for use as a control. HaCaT
cells and NHKs were transduced with these lentiviral particles
in accordance with the manufacturer’s instructions, and the
knockdown efficacy was assessed at the protein level by immuno-
blotting.
Measurement of HaCaT cell proliferation rate
HaCaT cells of each strain were seeded into six-well plates at a
density of 5 104 cells per well in the growth medium described
above. The next day, the medium was replaced with fresh medium,
and the numbers of cells in triplicate wells were counted by
trypsinization every 24 hours, from 48 to 120 hours after seeding.
Statistical analysis
Data are expressed as means±SEM. Comparisons among groups
were performed with the paired Student’s t-test. In all analyses,
Po0.05 was taken to indicate statistical significance.
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